Mendel Scott
- SEC CIK
- 0001515051
No open-market purchases or sales filed in the past year.
Current role at each company
- QTRX Quanterix CorpDirectoras of Jul 9, 2026
- QSI Quantum-Si IncDirectoras of May 20, 2026
- AKYA Akoya Biosciences, Inc.Directoras of Jul 10, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Mendel Scott as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
AKYA Akoya Biosciences, Inc.
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 12, 2023 (view filing) | Jun 12 | Same day | Mendel ScottDirector | PPurchase | +20.0K | $5.00 | +$100.0K | +235.3%28.5K after | |
| Nov 19, 2021 (view filing) | Nov 19 | Same day | Mendel ScottDirector | PPurchase | +8.50K | $13.16 | +$111.9K | New position8.50K after |